Withings has made a name for itself by making clinical-grade health technologies accessible to consumers. This week at CES 2025, the firm revealed two new products that fit the description nicely, one hardware and one software.
BPM Vision is the more notable. It’s a travel-size home blood pressure monitor, complete with interchangeable arm cuffs. The $130 device measures systolic and diastolic blood pressure, which can help users detect and control conditions like hypertension.
Withings says the system delivers “clinical accuracy,” displaying results on a large screen that also helps users correctly administer the test at home. The system is Wi-Fi enabled and sports a built-in battery that lasts upward of a year.
In addition to multiple cuff sizes, the Vision supports up to eight profiles, so multiple users can track their results on the same device. Tracking information will be made available through the Withings app. The system is set for U.S. release in April, pending FDA approval.
Cardio Check, meanwhile, launches Tuesday. The service is designed to offer round-the-clock heart monitoring, with access to board-certified cardiologists. The offering is designed for early detection of heart problems such as AFib.
The new feature is being made available through the $10/month Withings+ service. It’s compatible with the ScanWatch, ScanWatch 2, ScanWatch Nova, ScanWatch Nova Brilliant, Body Scan scale, BPM Core, and the BeamO, which was announced at last year’s show.
Subscriptions entitle users to up to four cardio checkups a year.
